Abstract
Background: Magnetic resonance imaging (MRI) is the actual gold standard for the radiological diagnosis of diabetic foot osteomyelitis (DFO).
Materials and Methods: MRI is not always available and many patients have contraindications. We evaluated the clinical value of 99mTc-antigranulocyte SPECT/CT (AGS) in eight DFO patients who underwent MRI before.
Results: The goal was to have a better clinical view on the extent of bone infection and to ameliorate the surgical approach for DFO. However, this additional scintigraphy did not change anything in the clinical approach.
Conclusion: We shared our experience with AGS for clinical management of complex DFO cases.
Keywords: Anti-granulocyte SPECT/CT, diabetic foot, osteomyelitis, clinical benefit, magnetic resonance imaging, comparisons.
[http://dx.doi.org/10.1007/s00256-020-03541-6] [PMID: 32699954]
[http://dx.doi.org/10.1097/MNM.0b013e328355880b] [PMID: 22692578]
[http://dx.doi.org/10.1007/s00259-013-2533-5] [PMID: 23963296]
[http://dx.doi.org/10.1053/j.semnuclmed.2018.03.003] [PMID: 30193651]
[http://dx.doi.org/10.2174/1381612824666180227094116] [PMID: 29484982]
[http://dx.doi.org/10.1016/j.ijid.2019.11.017] [PMID: 31759168]
[http://dx.doi.org/10.2337/dc17-0532] [PMID: 28733376]
[PMID: 27560470]
[PMID: 18036160]